炎症性肠病中的B细胞
Francisca A Castillo1, Bianca C Kern1, Eduardo J Villablanca1
1Division of Immunology and Respiratory Medicine, Department of Medicine, Solna, Karolinska Institutet and University Hospital, Stockholm 17176, Sweden; Center of Molecular Medicine, Stockholm 17176, Sweden.
Immunology letters
|August 22, 2025
概括
在炎症性肠道疾病 (IBD) 中,B细胞起着复杂的作用,超出了传统的T细胞焦点. 了解这些多样化的B细胞功能是开发IBD向治疗的关键.
科学领域:
- 免疫学
- 胃肠病学
- 细胞生物学
背景情况:
- 在历史上,炎症性肠病 (IBD) 被认为是T细胞介导的.
- 新出现的证据强调了B细胞在慢性肠道炎症中的重要作用.
- B细胞通常支持肠道免疫耐受性和粘膜健康.
研究的目的:
- 审查B细胞在IBD病变中的作用的不断发展的理解.
- 强调针对特定B细胞子集的选择性治疗策略的需要.
- 探索基于B细胞动态的精确免疫疗法的潜力.
主要方法:
- 关于IBDB细胞生物学现有科学文献的综述.
- 在肠道炎症中展示B细胞功能的实验模型的分析.
- 对针对B细胞的临床观察进行讨论.
主要成果:
- 在IBD中,B细胞区显著变化,血细胞增加和抗体反应发生变化.
- 在IBD过程中出现了Sca1+PD-L1+B细胞等亲炎性B细胞子集.
- 实验模型显示B细胞在IBD中具有有害和有益的作用.
- 广泛的B细胞消耗疗法 (例如,修复药) 的有限疗效表明复杂性.
结论:
- 在IBD中,B细胞具有多方面的作用,既起病原性作用又起调节性作用.
- 需要选择性治疗来向有害的B细胞,同时保留有益的B细胞.
- 进一步研究肠道B细胞的空间,表型和时间动态对于开发有效的IBD免疫疗法至关重要.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
382
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
382
Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189


